Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TAILORED-CHIP: Tailored vs Standard Antiplatelet Therapy in Complex PCI
NCT03465644Phase 4Completed
- Sponsor
- Duk-Woo Park
- Start
- Feb 2019
- Primary completion
- Feb 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of ticagrelor in coronary artery disease (CAD), sponsored by Duk-Woo Park. Started Feb 2019; status: completed.
02
Drugs
ticagrelor
03
Conditions
coronary artery disease (CAD)
Beyond the preview
Go deeper on NCT03465644.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03465644.